Printer Friendly

European Diabetes Market Report 2019 to 2025 - Covering Diabetes Monitoring, Treatment & Drug Delivery.

M2 PRESSWIRE-January 22, 2020-: European Diabetes Market Report 2019 to 2025 - Covering Diabetes Monitoring, Treatment & Drug Delivery

(C)1994-2020 M2 COMMUNICATIONS

RDATE:22012020

The "Diabetes Market Analysis, Size, Trends | Europe | 2019-2025" report has been added to ResearchAndMarkets.com's offering.

This report covers the European market for diabetes monitoring, treatment and drug delivery includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pen needles, insulin syringes and insulin pumps.

In 2018, the fastest-growing segment in the diabetes care market was the FGM market, which increased significantly in value. Abbott received CE Mark approval for FreeStyle Libre in September 2014 and for FreeStyle 2 in October 2018. The company also launched FGM in the U.S. market in late 2017 and has expanded to numerous international markets.

In the pipeline, Abbott is seeking to launch an update to its FGM platform, extending usage life and implanting other features, such as integration with insulin pumps. FGM is described as a hybrid between blood glucose meters and continuous glucose monitoring (CGM), because it measures interstitial fluid glucose levels through a sensor, but patients must perform manual scans by placing a device up to the sensor to view a reading.

FGM also eliminates the need for fingersticking, which is a common patient complaint about other glucose monitoring devices. The product was met with outstanding demand when it was first launched, resulting in product shortages in early 2015. Production capability issues have since then been resolved and unit sales have resumed at a growing rate. It is expected that growth will decelerate once a sizable installed base has been established in the European market.

Companies Mentioned

- Abbott

- Medtronic

- AgaMatrix

- Menarini

- Artsana

- Mendor

- Ascensia

- MyGlucoHealth

- B. Braun

- NeedleBay

- Becton Dickinson

- Neon Diagnostics

- Cambridge Sensors

- Nipro

- DarioHealth

- Novo Nordisk

- Dexcom

- Owen Mumford

- Eli

Key Topics Covered:

1. Executive Summary

2. Disease Overview

2.1 Introduction

2.1.1 Types of Diabetes

2.1.2 Diabetes Complications

2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes

2.1.4 Signs and Symptoms

2.1.5 Diabetes Monitoring

2.1.6 Treatment

2.1.7 Drug Delivery Systems

3. Product Assessment

3.1 Introduction

3.2 Product Portfolios

3.2.1 Blood Glucose Meter

3.2.1.1 Personal

3.2.1.2 Professional

3.2.2 Blood Glucose Test Strip

3.2.3 Lancet

3.2.4 Continuous Glucose Monitoring

3.2.5 Flash Glucose Monitoring

3.2.5.1 Sensor

3.2.5.2 Reader

3.2.6 Insulin

3.2.6.1 Insulin Types

3.2.6.1.1 Rapid-Acting Insulin Analog

3.2.6.1.2 Regular Human Insulin

3.2.6.1.3 Intermediate-Acting Human Insulin

3.2.6.1.4 Long-Acting Insulin Analog

3.2.6.1.5 Ultra-Long-Acting Insulin Analog

3.2.6.1.6 Premixed Insulin

3.2.7 Insulin Pen

3.2.8 Insulin Syringe

3.2.9 Insulin Pump

3.3 Regulatory Issues and Recalls

3.4 Clinical Trials

4. European Diabetes Monitoring, Treatment And Drug Delivery Market Overview

4.1 Currency Exchange Rate

4.2 Market Overview

4.3 Trend Analysis By Segment

4.4 Drivers And Limiters

4.4.1 Market Drivers

4.4.2 Market Limiters

4.5 Competitive Market Share Analysis

4.6 Mergers And Acquisitions

4.7 Company Profiles

4.7.1 Abbott

4.7.2 Ascensia

4.7.3 Becton Dickinson

4.7.4 Dexcom

4.7.5 Eli Lilly

4.7.6 Insulet

4.7.7 LifeScan

4.7.8 Medtronic

4.7.9 Novo Nordisk

4.7.10 Roche

4.7.11 Sanofi

4.8 Swot Analysis

5. Country Profiles

5.1 Introduction

5.2 Germany

5.3 France

5.4 United Kingdom

5.5 Italy

5.6 Spain

5.7 Benelux

5.8 Scandinavia

5.9 Austria

5.10 Switzerland

5.11 Portugal

6. Blood Glucose Meter Market

6.1 Introduction

6.2 Market Analysis and Forecast

6.3 Drivers And Limiters

6.3.1 Market Drivers

6.3.2 Market Limiters

6.4 Competitive Market Share Analysis

7. Blood Glucose Test Strip Market

8. Lancet Market

9. Continuous Glucose Monitoring Market

10. Flash Glucose Monitoring Market

11. Insulin Market

12. Insulin Pen Needle Market

13. Insulin Syringe Market

14. Insulin Pump Market

For more information about this report visit https://www.researchandmarkets.com/r/mgnl6t

CONTACT:

ResearchAndMarkets.com,

Laura Wood, Senior Press Manager

press@researchandmarkets.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.m2.com on the world wide web. Inquiries to info@m2.com)).
COPYRIGHT 2020 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2020 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Presswire
Article Type:Report
Date:Jan 22, 2020
Words:780
Previous Article:Raising banks’ Loan to Deposit Ratio while minimising risk.
Next Article:2020 Global Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio...
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters